Evidence map›Paper›PMID 23205323›Full record

ArticleAmerican journal of clinical and experimental immunology2012

Regulation of Ras signal transduction during T cell development and activation.

Philip E Lapinski, Philip D King

Abstract read
In one paragraph

Article in American journal of clinical and experimental immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. CD6-mediated inhibition of T cell activation via modulation of Ras.Cell communication and signaling : CCS · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Ras isoforms: signaling specificities in CD40 pathway.Cell communication and signaling : CCS · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Philip E LapinskiDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Philip D King

Funding

Control of T cell activation by the TSAd adapter proteinR01AI050699 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KING, PHILIP D · 2002 to 2006
$1.4M
RASA1-mediated control of lymphatic vessel growth and functionR01HL096498 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KING, PHILIP D · 2009 to 2012
$1.4M
NHLBI NIH HHS R01 HL096498NIAID NIH HHS R01 AI050699
6 · The paper itself

Abstract

T cell receptor-induced activation of the Ras signaling pathway is essential for T cell development, proliferation and differentiation. Given the central role of Ras in T cell biology its activation must be tightly regulated. However, precisely how Ras activation is controlled in T cells is not completely understood. In this review, we provide a summary of the known factors and mechanisms involved in positive and negative regulation of Ras activation in the T cell lineage.

Identifiers

PMID23205323
PMCPMC3510699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.